References
- Evans WS, Sollenberger MJ, Booth RA, et al. Contemporary aspects of discrete peak-detection algorithms. II. The paradigm of the luteinising hormone pulse signal in women. Endocrine Rev 1992;13:81–102
- Fillicori M, Santoro N, Merriam GR, etal. Charac-terisation of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986; 62:1136–44
- Nippoldt T, Reame N, Kelch R, et al. The roles of estradiol and progesterone in decreasing LH pulse frequency in the luteal phase ofthe menstrual cycle. J Clin Endocrinol Metab 1989;69:67–76
- Hemrika DJ, Slaats EH, Kennedy JC, etal. Pulsatile luteinizing hormone secretion in long-term oral contraceptive users. J Clin Endocrinol Metab 1993; 77:420–6
- Leyendecker G, Wildt L, Brensing KA, et al. Pulsatility of serum LH in pathological conditions. Horm Res 1987;28:139–48
- Urban RJ, Evans WS, Rogol AD, etal. Contemporary aspects of discrete peak-detection algorithms. I The paradigm of the LH pulse signal in men. Endocrine Rev 1988;9:3–37
- Chappel SC, Howles C. Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Human Reprod 1991;6:1206–12
- Schoemaker J, Hemrika D. Pulsatile pattern o f LH secretion in relation to the sex steroid milieu. In: Rossmanith WG, Scherbaum WA, eds. Neuroendo-crinology of Sex Steroids. Berlin, New York: Walter de Gruyter, 1992:125–34
- Marshall JC, Case GD, Valk TW, et al. Selective inhibition of FSH secretion by estradiol. Mecha-nism for modulation of gonadotropin responses to low-dose gonadotropin-releasing h ormo ne. J Clin Invest 1983;71:248–57
- Dericks-Tan ICE, Gudacker V, Taubert HD. Influence of oral contraceptives on integrated secretion of gonadotropins. Contraception 1992;46: 369–77
- Akerlund M, Rode A, Westergaard J. Comparative profiles ofreliability, cycle control and site effects of two oral contraceptive formulations containing 15014 desogestrel and either 30 gg or 2014 ethinyl oestradiol. Br J Obstet Gynaecol 1993;100: 832–8
- Fitzgerald C, Feichtinger W, Spona J, etal. A com-parison of the effects of two monophasic low-dose contraceptives on the inhibition of ovulation. Adv Contracept 1994;10:5–18
- Egarter C, Putz M, Strohmer H, et al. Ovarian function during low-dose oral contraceptive use. Contraception 1995;51:329–33
- Gaspard UI, Romus MA, Gillain D, et al. Plasma hormone level in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Contraception 1983; 27:577–89
- Hartwich R. Minisiston versus Gravistat 125 — emn V ergleich von zwei Jenapharm-Präparaten. Medicamentum 1987;28:60–4
- Kuhl H, Gahn H, Romberg C, etal. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parametres: I. Effects upon sexual hormone levels. Contraception 1985;31:583–93
- Goo dmannRL, Bittmann EL, Foster DL, etal. The endocrine basis of the synergistic suppression ofLH by estradiol and progesterone. Endocrinology 1981; 109:1414–7
- Soules MR, Steiner RA, Clifton DK, et al. Proges-terone modulation of pulsatile LH secretion in normal women. J Clin Endocrinol Metab 1984;38: 378–83
- Hemrika DJ, Slaats EH, Kennedy JC, etal. Pulsatile hormone secretion during the first and fourth cycle on two different oral contraceptives containing gestodene. Acta Endocrinol 1993;129:229–36
- Dericks-Tan JSE, Koch P, Taubert HD. Synthesis and release of gonadotropins: effect of an oral con-traceptive. Obstet Gynecol 1983;62:687–90